logo
AAT Bioquest

Granzyme B Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
(3S)-3-[[(2S,11S)-11-[[(2S,3S)-2-[Acetyl(methyl)amino]-3-methylpentanoyl]amino]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carbonyl]amino]-4-oxo-4-(5-phenyl-1,3,4-oxadiazol-2-yl)butanoic acidKi7.0 [1]
(2R)-2-[[(2R)-2-[[2-[[2-[[2-[[(2S)-2-[[(1R,7S,10S,13S,16S,22S,25S,28S,40R,43S,46S,49S,52S,58S,61S)-40-Acetamido-43,52-bis(2-amino-2-oxoethyl)-13-(carboxymethyl)-46-[(1R)-1-hydroxyethyl]-10,49,61-tris(1H-indol-3-ylmethyl)-16-methyl-25-(2-methylpropyl)-2,8,11,14,17,23,26,41,44,47,50,53,59,62-tetradecaoxo-30,38,65-trithia-3,9,12,15,18,24,27,42,45,48,51,54,60,63-tetradecazahexacyclo[32.29.3.132,36.03,7.018,22.054,58]heptahexaconta-32,34,36(67)-triene-28-carbonyl]amino]propanoyl]-methylamino]acetyl]-methylamino]acetyl]-methylamino]acetyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoic acidKi50000.0 [1]
(2R)-2-[[(2R)-2-[[2-[[2-[[2-[[(2S)-2-[[(7R,10S,13S,16S,22S,25S,28S,31R,34S,37S,45S,48S,51R)-51-Acetamido-45-benzyl-10-[(2S)-butan-2-yl]-34-(4-carbamimidamidobutyl)-13-(carboxymethyl)-48-(hydroxymethyl)-22,25,37-tris[(4-hydroxyphenyl)methyl]-9,12,15,21,24,27,30,33,36,39,44,47,50-tridecaoxo-28-propan-2-yl-5,53,58-trithia-8,11,14,20,23,26,29,32,35,38,43,46,49-tridecazapentacyclo[29.25.3.13,55.016,20.040,43]hexaconta-1(56),2,55(60)-triene-7-carbonyl]amino]propanoyl]-methylamino]acetyl]-methylamino]acetyl]-methylamino]acetyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoic acidKi50000.0 [1]
(7R,10S,13S,21S,24S,27S,30S,33S,36S,39S,42S,45R)-7-Acetamido-36-(3-amino-3-oxopropyl)-13-benzyl-24-(4-carbamimidamidobutyl)-39-(carboxymethyl)-10-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-33-(1H-imidazol-5-ylmethyl)-30-methyl-42-(2-methylpropyl)-8,11,14,19,22,25,28,34,37,40,43-undecaoxo-5,47,52-trithia-9,12,15,20,23,26,29,32,35,38,41,44-dodecazatetracyclo[25.23.3.13,49.015,18]tetrapentaconta-1,3(54),49-triene-45-carboxylic acidKi50000.0 [1]
(2S,11S)-11-[[(2S,3S)-3-Methyl-2-[(2-phenylacetyl)amino]pentanoyl]amino]-12-oxo-N-(1H-pyrazol-4-ylmethyl)-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamideKi13.0 [1]
(3S)-3-[[(2S,11S)-11-[[(2S,3S)-2-[Acetyl(methyl)amino]-3-methylpentanoyl]amino]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carbonyl]amino]-5-methoxy-4,5-dioxopentanoic acidKi16.0 [1]
(2S,11S)-11-[[(2S,3S)-2-[Acetyl(methyl)amino]-3-methylpentanoyl]amino]-12-oxo-N-(2H-triazol-4-ylmethyl)-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamideKi38.0 [1]
(2R)-2-[[(2S,11S)-11-[[(2S,3S)-2-[Acetyl(methyl)amino]-3-methylpentanoyl]amino]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carbonyl]amino]-3-oxopropanoic acidKi8.0 [1]
(3S)-3-[[(2S)-1-[2-[[(2S,3S)-2-Acetamido-3-methylpentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoic acidKi270.0 [1]
(3S)-3-[[2-[3-[[(2S,3S)-2-Acetamido-3-methylpentanoyl]amino]-2-oxopyridin-1-yl]acetyl]amino]-4-oxobutanoic acidKi133.0 [1]
(3S)-3-[[(3S,6S,8As)-6-[[(2S,3S)-2-acetamido-3-methylpentanoyl]amino]-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-4-oxobutanoic acidKi122.0 [1]
(3S)-3-[[(2S)-1-[2-[[(2S,3S)-2-Acetamido-3-methylpentanoyl]amino]acetyl]-2,3-dihydroindole-2-carbonyl]amino]-4-oxobutanoic acidKi13.0 [1]
(3S)-3-[[(2S,11S)-11-[[(2S,3S)-2-[Acetyl(methyl)amino]-3-methylpentanoyl]amino]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carbonyl]amino]-5-[(4-fluorophenyl)methylsulfanyl]-4-oxopentanoic acidKi2300.0 [1]
(3S)-3-[[(2S,11S)-11-[[(2S,3S)-2-[Acetyl(methyl)amino]-3-methylpentanoyl]amino]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carbonyl]amino]-4-(1,3-benzothiazol-2-yl)-4-oxobutanoic acidKi85.0 [1]
(2S,11S)-11-[[(2R)-3-Methyl-2-pyridin-2-ylbutanoyl]amino]-12-oxo-N-(2H-triazol-4-ylmethyl)-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamideKi75.0 [1]
(2S,11S)-11-[[(2S,3S)-2-[Acetyl(methyl)amino]-3-methylpentanoyl]amino]-12-oxo-N-(2H-tetrazol-5-ylmethyl)-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamideKi74.0 [1]
(2S,11S)-11-[[(2S,3S)-2-[Acetyl(methyl)amino]-3-methylpentanoyl]amino]-12-oxo-N-[(3-oxo-1,2-oxazol-5-yl)methyl]-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamideKi360.0 [1]
3-[[(2S,11S)-11-[[(2S,3S)-2-[Acetyl(methyl)amino]-3-methylpentanoyl]amino]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carbonyl]amino]propanoic acidKi580.0 [1]
(4S)-4-[[(2S,3S)-2-Acetamido-3-methylpentanoyl]amino]-5-[(2S)-2-[[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acidKi80.0 [1]
(2S,11S)-11-[[(2S,3S)-2-[[2-(1-Benzothiophen-3-yl)acetyl]amino]-3-methylpentanoyl]amino]-12-oxo-N-(1H-pyrazol-4-ylmethyl)-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamideKi7.0 [1]
(3S)-3-[[(2S,11S)-11-[[(2S,3S)-2-Acetamido-3-methylpentanoyl]amino]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carbonyl]amino]-4-oxobutanoic acidKi8.0 [1]
(3S)-3-[[(2S,11S)-11-[[(2S,3S)-2-Acetamido-3-methylpentanoyl]amino]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carbonyl]amino]-4-oxo-4-(5-phenyl-1,3,4-oxadiazol-2-yl)butanoic acidKi7.0 [1]
(3S)-3-[[(2S,11S)-11-[[(2S,3S)-2-Acetamido-3-methylpentanoyl]amino]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carbonyl]amino]-4-(1,3-benzothiazol-2-yl)-4-oxobutanoic acidKi85.0 [1]
[(2R)-3-[[(2S)-1-[[(2S,5S,8S,11R,12S,15Z,18S,21R)-2,5-Dibenzyl-8-[(2R)-butan-2-yl]-15-ethylidene-21-hydroxy-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-2-methoxy-3-oxopropyl] hydrogen sulfateIC5010000.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Granzyme B Inhibitors (IC50, Ki)." AAT Bioquest, Inc.8 May2024https://www.aatbio.com/data-sets/granzyme-b-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024May 8). Quest Database™ Granzyme B Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/granzyme-b-inhibitors-ic50-ki.
BibTeXEndNoteRefMan